Navigation Links
Fox Chase Cancer Center scientists identify immune-system mutation

A team of Fox Chase Cancer Center scientists led by immunologist Dietmar J. Kappes, Ph.D., has identified the genetic mutation that keeps a mouse strain from developing white blood cells, or lymphocytes, called helper T cells. The report by Kappes and his colleagues appears in the Feb. 24 issue of Nature.

Kappes' laboratory first discovered the mice with this naturally occurring defect in Fox Chase's laboratory animal facility in 1997. Known as "helper deficient" or HD mice, they are proving to be useful for exploring the pathways of lymphocyte development, according to Kappes.

Helper T cells, so called because they arise from the thymus gland, are essential for combating intracellular viral and bacterial infections (cell-mediated immunity) and also for helping other white blood cells (B cells, derived from bone marrow) generate antibodies against foreign agents that enter the body. Other T cells are known as killer cells because they attack foreign invaders more directly.

"The maturation of T cells involves key branch points at which cells choose one of two different pathways, going on to become helper cells or killer cells," Kappes said. His goal is to understand how T cells specialize to do different jobs.

Commitment to the helper or killer lineages correlates precisely with the restriction of the T-cell receptor toward either class I or class II major histocompatibility complex (MHC) molecules. Most helper T cells carry a surface protein called CD4, which is attracted to class II MHC. Killer cells carry the CD8 protein, attracted to class I MHC. However, the underlying molecular pathways that regulate this process have remained obscure.

"The mutant HD mice are unable to generate mature helper T cells, even though their immature T cells carry the CD4 protein," Kappes explained. "Instead, the mutation redirects them to the killer-cell pathway.

"Our new study identifies this defect as a point mutation in the zinc finge r transcription factor Th-POK. We show that when the normal form of this factor is active in all developing lymphocytes, it can redirect would-be killer cells to the CD4 helper T cell lineage. This indicates that Th-POK is a master regulator of the maturation process."

Understanding the development of critical components of the immune system can contribute to medical advances in stimulating desirable immune responses and halting undesirable immune reactions, Kappes said. This understanding can further progress against various immune disorders, allergies and certain cancers, such as those of the blood and bone marrow, that involve a compromised immune system.

"As one example, a decrease in the number of CD4 T cells is the primary mechanism by which HIV causes AIDS," Kappes said.

The helper-deficient mice his team discovered represent the second time that a naturally occurring mutant strain has been found and bred at Fox Chase. In 1981, the laboratory group of Melvin Bosma, Ph.D., discovered mice with severe combined immune deficiency (SCID), a condition that also affects humans. In addition to providing a unique animal model to study the SCID syndrome, SCID mice have become a highly valuable tool for studying the immune system and are now used by scientists worldwide.

Kappes' co-authors on the new Nature paper include Fox Chase postdoctoral associates Xiao He, Ph.D., Xi He, Ph.D., and Vibhuti P. Dave, Ph.D., (who is now at the Institute of Clinical Research of Montreal); Fox Chase scientific technician Yi Zhang; Xiang Hua, manager of Fox Chase's transgenic mouse facility; Fox Chase research associate Emmanuelle Nicolas, Ph.D.; and Weihong Xu, Ph.D., and Bruce A. Roe, Ph.D., both of the University of Oklahoma's department of chemistry and biochemistry.


'"/>

Source:Fox Chase Cancer Center


Related biology news :

1. Novel Therapy Tested in Mice Could Chase Away Cat Allergies
2. Fox Chase study shows that weakened T-cell receptor signals change T-cell lineage
3. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
4. Jump-starting T Cells In Skin Cancer
5. Deficient DNA Repair Capacity Associated With Increased Risk Of Breast Cancer
6. Breakthrough Microarray-based Technology for the Study of Cancer
7. Yale Scientists Find MicroRNA Regulates Ras Cancer Gene
8. Fundamental Finding Yields Insight into Stem Cells, Cancer; Opens Door to Drug Discovery
9. First-ever Compounds To Target Only Metastatic Cells Are Highly Effective Against Breast, Prostate, And Colon Cancers
10. Gene Vaccine Protects Mice Against Development Of Her2/neu Breast Cancer
11. New Breast Cancer Test Could Save Lives
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/15/2016)... 2016   WaferGen Bio-systems, Inc. (NASDAQ: ... announced today that on December 13, 2016, it received ... Nasdaq Stock Market LLC which acknowledged that, as of ... common stock had been at $1.00 or greater for ... with Listing Rule 5550(a)(2) of the Nasdaq Stock Market. ...
(Date:12/12/2016)... , Dec. 12, 2016  Researchers at Trinity ... for graphene by combining the material with Silly ... sensitive pressure detector able to sense pulse, blood ... small spider.  The research team,s ... be read here:  http://science.sciencemag.org/content/354/6317/1257 ...
(Date:12/7/2016)... Avanade is helping Williams Martini Racing, one of ... biometric data in order to critically analyse every aspect ... against their rivals after their impressive, record-breaking pit stop ... with Williams during the 2016 season to capture and ... rate, temperature and peak acceleration) for key members of ...
Breaking Biology News(10 mins):
(Date:1/17/2017)... YORK , Jan. 17, 2017 ... health coaching, is the first to offer fully ... obesity. Noom,s Spanish diabetes prevention and ... the reach and accessibility of lifestyle interventions among ... developing these conditions. Noom,s robust food database, program-specific ...
(Date:1/17/2017)... Thornton Cleveleys, UK (PRWEB) , ... ... ... clinical results presented by surgeons at the 2016 annual meeting of the ... and beneficial clinical outcomes, for patients in the majority of cases, when ...
(Date:1/17/2017)... ... January 17, 2017 , ... Diagenode, a leading global ... collaboration with the Heidelberg University Hospital and the German Cancer Research Center (DKFZ) ... company’s successful launch of its CATS (Capture and Amplification by Tailing and ...
(Date:1/16/2017)...   Valentin A. Pavlov, PhD , associate investigator, ... CEO of The Feinstein Institute for Medical Research ... the nervous system regulates the immune system, which will ... devices to treat disease and injury. The analysis ... The paper examines various studies which further define ...
Breaking Biology Technology: